title: [Ablative therapy for immune hyperthyroidism in patients with ophthalmopathy].
abstract: The influence of ablative treatment of Graves' disease on the course of endocrine ophthalmopathy is discussed controversially. Data are inhomogeneous, because some studies were performed retrospectively, some prospectively, because of different follow up periods and different patient groups. In principal near total resection seems to influence endocrine ophthalmopathy in a positive way, due to the removal of thyroid antigen. Most studies also demonstrate that treatment using radioiodine has a negative influence on ophthalmopathy, because the course of disease is worsening in up to one third of patients. There is also consensus that treatment of Graves' disease with radioiodine should be performed only by concomitant administration of glucocorticoids. The early administration of L-thyroxine after radio-iodine therapy of Graves' disease seems to have a positive influence on the course of disease, whereas additional treatment with methimazole has no positive influence on endocrine ophthalmopathy.
authors.affiliation: Abteilung für Nuklearmedizin und Endokrinologie, PET-Zentrum, Landeskrankenhaus Klagenfurt, St. Veiterstrasse 47, A-9020 Klagenfurt. peter.lind@lkh-klu.at
authors.forename: P
authors.initials: P
authors.lastname: Lind
mesh_terms: D003937:Diagnosis, Differential; D005094:Exophthalmos / Q000532:radiotherapy* / Q000601:surgery; D006111:Graves Disease / Q000532:radiotherapy* / Q000601:surgery*; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use
chemical_list: D007457:Iodine Radioisotopes